The study, conducted by the Global eHealth Unit at the Imperial College London, has found that the majority of insulin dosing apps are unreliable and put patients at risk of getting incorrect doses of ...
Following in the footsteps of Eli Lilly and Roche, Sanofi has quietly received FDA clearance for a smartphone app with a built-in insulin dose calculator. According to FDA documents, the app, cleared ...
In the Phase 3a ONWARDS 5 randomized trial, once-weekly insulin icodec titrated with a dosing guide app demonstrated superior reduction in HbA1c levels and similarly low hypoglycemia rates compared ...
A 52-week, randomized, open-label, parallel-group, phase 3a trial with real-world elements was conducted at 176 sites in seven countries. A total of 1085 insulin-naive patients with type 2 diabetes ...
Apple's review process for the apps angling to get into the AppStore has long been a pain point for developers. This week physician-led medical app review site iMedicalApps pointed out that a number ...
Need to figure out how much insulin to administer throughout the day and stick to those fluctuating doses over time? There’s an app for that. That insulin titration app—Amalgam Rx’s iSage Rx—will soon ...
The prescription-only device works with integrated continuous glucose monitors and alternate controller enabled pumps. The Food and Drug Administration (FDA) has cleared Tidepool Loop, an automated ...
Tresiba is a long-acting insulin prescribed to manage blood sugar levels in adults and children over 1 year old with type 1 and type 2 diabetes. The appropriate Tresiba dosage varies depending on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results